Compare Lupin Ltd with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs DIVIS LABORATORIES - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN DIVIS LABORATORIES LUPIN/
DIVIS LABORATORIES
 
P/E (TTM) x 107.6 35.9 299.9% View Chart
P/BV x 2.4 6.7 36.6% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 LUPIN   DIVIS LABORATORIES
EQUITY SHARE DATA
    LUPIN
Mar-19
DIVIS LABORATORIES
Mar-19
LUPIN/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs9861,639 60.1%   
Low Rs7201,115 64.6%   
Sales per share (Unadj.) Rs369.5186.3 198.3%  
Earnings per share (Unadj.) Rs13.451.0 26.3%  
Cash flow per share (Unadj.) Rs37.457.3 65.2%  
Dividends per share (Unadj.) Rs016.00 0.0%  
Dividend yield (eoy) %01.2 0.0%  
Book value per share (Unadj.) Rs303.7261.8 116.0%  
Shares outstanding (eoy) m452.49265.47 170.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.37.4 31.2%   
Avg P/E ratio x63.627.0 235.5%  
P/CF ratio (eoy) x22.824.0 95.0%  
Price / Book Value ratio x2.85.3 53.4%  
Dividend payout %031.4 0.0%   
Avg Mkt Cap Rs m386,064365,592 105.6%   
No. of employees `00017.711.8 149.3%   
Total wages/salary Rs m31,5135,423 581.1%   
Avg. sales/employee Rs Th9,453.84,175.1 226.4%   
Avg. wages/employee Rs Th1,782.0457.7 389.3%   
Avg. net profit/employee Rs Th343.01,141.8 30.0%   
INCOME DATA
Net Sales Rs m167,18249,463 338.0%  
Other income Rs m3,6401,556 233.9%   
Total revenues Rs m170,82251,019 334.8%   
Gross profit Rs m28,82218,718 154.0%  
Depreciation Rs m10,8501,689 642.4%   
Interest Rs m3,07835 8,795.1%   
Profit before tax Rs m18,53418,551 99.9%   
Minority Interest Rs m-890-   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,4000-   
Tax Rs m9,0175,023 179.5%   
Profit after tax Rs m6,06613,527 44.8%  
Gross profit margin %17.237.8 45.6%  
Effective tax rate %48.727.1 179.7%   
Net profit margin %3.627.3 13.3%  
BALANCE SHEET DATA
Current assets Rs m138,53646,501 297.9%   
Current liabilities Rs m61,2998,468 723.9%   
Net working cap to sales %46.276.9 60.1%  
Current ratio x2.35.5 41.2%  
Inventory Days Days84131 64.0%  
Debtors Days Days11286 131.0%  
Net fixed assets Rs m127,51625,797 494.3%   
Share capital Rs m905531 170.5%   
"Free" reserves Rs m136,51768,962 198.0%   
Net worth Rs m137,42269,493 197.7%   
Long term debt Rs m66,4170-   
Total assets Rs m279,49480,383 347.7%  
Interest coverage x7.0531.0 1.3%   
Debt to equity ratio x0.50-  
Sales to assets ratio x0.60.6 97.2%   
Return on assets %3.316.9 19.4%  
Return on equity %4.419.5 22.7%  
Return on capital %8.926.7 33.3%  
Exports to sales %00-   
Imports to sales %024.6 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA12,187 0.0%   
Fx inflow Rs m59,41441,238 144.1%   
Fx outflow Rs m22,28212,405 179.6%   
Net fx Rs m37,13228,833 128.8%   
CASH FLOW
From Operations Rs m16,6609,543 174.6%  
From Investments Rs m-32,825-6,854 478.9%  
From Financial Activity Rs m7,441-2,459 -302.6%  
Net Cashflow Rs m-8,724230 -3,799.5%  

Share Holding

Indian Promoters % 46.6 52.0 89.6%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 11.8 95.8%  
FIIs % 31.9 19.0 167.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 17.2 58.7%  
Shareholders   98,259 31,796 309.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   FULFORD INDIA  SUVEN LIFESCIENCES  CIPLA  WOCKHARDT  VENUS REMEDIES  

Compare LUPIN With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Nov 15, 2019 (Close)

TRACK LUPIN

LUPIN - NOVARTIS COMPARISON

COMPARE LUPIN WITH

MARKET STATS